418 filings
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
8-K
SLNO
Soleno Therapeutics Inc
29 Apr 24
First Ever Breakthrough Designation for a Drug Being Developed for PWS
4:08pm
ARS
2023 FY
SLNO
Soleno Therapeutics Inc
22 Apr 24
Annual report to shareholders
5:06pm
DEF 14A
SLNO
Soleno Therapeutics Inc
Definitive proxy
22 Apr 24
4:31pm
8-K
SLNO
Soleno Therapeutics Inc
22 Apr 24
Departure of Directors or Certain Officers
4:15pm
8-K
3grdp27aa ghpl
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
S-8
ksd00
31 Jan 24
Registration of securities for employees
4:19pm
8-K
12c98r1l9z8gsxbner8q
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-8
ueqjt9fz
17 Jan 24
Registration of securities for employees
4:06pm
8-K
qqa3naty4aehuh tr
5 Jan 24
Departure of Directors or Certain Officers
4:16pm
S-3ASR
nxrxi2s5bt6 tp
2 Jan 24
Automatic shelf registration
4:06pm
EFFECT
hroondl9ep
1 Nov 23
Notice of effectiveness
12:15am
UPLOAD
aaozd4c0rqwnu
27 Oct 23
Letter from SEC
12:00am
CORRESP
u9p6btg4 qpzrtin13i8
27 Oct 23
Correspondence with SEC
12:00am
D
k87kz
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
8-K
f4dkg
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
1kfew56 1zg
29 Sep 23
Prospectus supplement for primary offering
4:51pm